SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Alethia BioTherapeutics, Inc. Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline